Editorially independent content, supported with advertising
09.22.21
Lorraine M. Provencher, MD, and Constance O. Okeke, MD, MSCE, join Inder Paul Singh, MD, to discuss new molecules and mechanisms of action. How do these new medications change the way physicians treat glaucoma?
12.10.21
Dose & Delivery: Defining Target IOP RangesNathan M. Radcliffe, MD; Davinder S. Grover, MD, MPH; and Inder Paul Singh, MD
09.22.21
Dose & Delivery: New Mechanisms of ActionLorraine M. Provencher, MD; Constance O. Okeke, MD, MSCE; and Inder Paul Singh, MD
06.22.21
Dose & Delivery: Defining Controlled GlaucomaDeborah Ristvedt, DO; Mark Gallardo, MD; and Inder Paul Singh, MD
04.16.21
Dose & Delivery: Evolutions in Glaucoma ManagementNathan Radcliffe, MD; Steven R. Sarkisian Jr, MD; and Inder Paul Singh, MD